Skip to main content
. Author manuscript; available in PMC: 2013 Aug 9.
Published in final edited form as: J Med Chem. 2012 Jul 24;55(15):6784–6801. doi: 10.1021/jm300353r

Figure 4.

Figure 4

Procognitive effects of NO-chimeras evaluated in the scopolamine-induced memory deficit model using the STPA task. Scopolamine was administered 30 min and drug was administered 20 min prior to the start of training and memory was tested 24 h after training and drug treatment. NO-chimeras, 28, 29, 32a, 32b, 42 and 43 (***, p<0.01, compared with vehicle), and 40 (**, p<0.05, compared with vehicle) significantly reversed the scopolamine induced memory deficit. Data were obtained from at least 5 mice per group.